{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:31:39Z","timestamp":1768069899466,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10689-011-9491-5","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T08:50:49Z","timestamp":1321433449000},"page":"123-129","source":"Crossref","is-referenced-by-count":27,"title":["Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18\u00a0years of age: implications for surveillance"],"prefix":"10.1007","volume":"11","author":[{"given":"Karin Y.","family":"van Spaendonck-Zwarts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhanna","family":"Badeloe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoukje F.","family":"Oosting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd","family":"Hovenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J. F.","family":"Semmelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeroen A.","family":"van Moorselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Hein","family":"van Waesberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjen R.","family":"Mensenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred H.","family":"Menko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,16]]},"reference":[{"key":"9491_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan WM, Srinivasan R, Schmidt LS (2010) The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 7:277\u2013285","journal-title":"Nat Rev Urol"},{"key":"9491_CR2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1159\/000320892","volume":"118","author":"ER Maher","year":"2011","unstructured":"Maher ER (2011) Genetics of familial renal cancers. Nephron Exp Nephrol 118:e21\u2013e26","journal-title":"Nephron Exp Nephrol"},{"key":"9491_CR3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","volume":"31","author":"MJ Merino","year":"2007","unstructured":"Merino MJ, Torres-Cabala C, Pinto P et al (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578\u20131585","journal-title":"Am J Surg Pathol"},{"key":"9491_CR4","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","volume":"177","author":"RL Grubb III","year":"2007","unstructured":"Grubb RL III, Franks ME, Toro J et al (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074\u20132080","journal-title":"J Urol"},{"key":"9491_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen HJ (2011) Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 10:397\u2013411","journal-title":"Fam Cancer"},{"key":"9491_CR6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IPM Tomlinson","year":"2002","unstructured":"Tomlinson IPM, Alam NA, Rowan AJ et al (2002) The multiple leiomyoma consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cancer. Nat Genet 30:406\u2013410","journal-title":"Nat Genet"},{"key":"9491_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archderm.141.2.199","volume":"141","author":"NA Alam","year":"2005","unstructured":"Alam NA, Barclay E, Rowan AJ et al (2005) Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. Arch Dermatol 141:199\u2013206","journal-title":"Arch Dermatol"},{"key":"9491_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","volume":"43","author":"M-H Wei","year":"2006","unstructured":"Wei M-H, Toure O, Glenn GM et al (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18\u201327","journal-title":"J Med Genet"},{"key":"9491_CR9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-9-20","volume":"9","author":"JP Bayley","year":"2008","unstructured":"Bayley JP, Launonen V, Tomlinson IP (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9:20","journal-title":"BMC Med Genet"},{"key":"9491_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10689-009-9312-2","volume":"9","author":"P Vahteristo","year":"2010","unstructured":"Vahteristo P, Koski TA, Naatsaari L et al (2010) No evidence for a genetic modifier for renal cancer risk in HLRCC syndrome. Fam Cancer 9:245\u2013251","journal-title":"Fam Cancer"},{"key":"9491_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10689-009-9306-0","volume":"9","author":"I Alrashdi","year":"2010","unstructured":"Alrashdi I, Levine S, Paterson J et al (2010) Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient. Fam Cancer 9:239\u2013243","journal-title":"Fam Cancer"},{"key":"9491_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","volume":"79","author":"DL Smit","year":"2011","unstructured":"Smit DL, Mensenkamp AR, Badeloe S et al (2011) Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet 79:49\u201359","journal-title":"Clin Genet"},{"key":"9491_CR13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2133.2008.09000.x","volume":"160","author":"S Badeloe","year":"2009","unstructured":"Badeloe S, van Spaendonck-Zwarts KY, van Steensel MA et al (2009) Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer? Br J Dermatol 160:707\u2013709","journal-title":"Br J Dermatol"},{"key":"9491_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jdermsci.2008.04.005","volume":"51","author":"S Badeloe","year":"2008","unstructured":"Badeloe S, Bladergroen RS, Jonkman MF et al (2008) Hereditary multiple cutaneous leiomyoma resulting from novel mutations in the fumarate hydratase gene. J Dermatol Sci 51:139\u2013143","journal-title":"J Dermatol Sci"},{"key":"9491_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555553409416","volume":"53","author":"WB Reed","year":"1973","unstructured":"Reed WB, Walker R, Horowitz R (1973) Cutaneous leiomyomata with uterine leiomyomata. Acta Dermat Venereol 53:409\u2013416","journal-title":"Acta Dermat Venereol"},{"key":"9491_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2230.2004.01675.x","volume":"30","author":"I Chan","year":"2005","unstructured":"Chan I, Wong T, Martinez-Mir A et al (2005) Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cancer. Clin Exp Dermatol 30:75\u201378","journal-title":"Clin Exp Dermatol"},{"key":"9491_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2005.036400","volume":"43","author":"HJ Lehtonen","year":"2006","unstructured":"Lehtonen HJ, Kiuru M, Ylisaukko-oja SK et al (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523\u2013526","journal-title":"J Med Genet"},{"key":"9491_CR18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.humpath.2006.10.011","volume":"38","author":"HJ Lehtonen","year":"2007","unstructured":"Lehtonen HJ, Blanco I, Piulats JM et al (2007) Conventional renal cancer in a patient with fumarate hydratase mutation. Hum Pathol 38:793\u2013796","journal-title":"Hum Pathol"},{"key":"9491_CR19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncponc0773","volume":"4","author":"M Al Refae","year":"2007","unstructured":"Al Refae M, Wong N, Patenaude F et al (2007) Hereditary leiomyomatosis and renal cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 4:256\u2013261","journal-title":"Nat Clin Pract Oncol"},{"key":"9491_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D382P000CW","volume":"14","author":"H Ghaninejad","year":"2008","unstructured":"Ghaninejad H, Moeineddin F, Rajaee A et al (2008) Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report. Dermatol Online J 14:16","journal-title":"Dermatol Online J"},{"key":"9491_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cancergencyto.2008.01.010","volume":"183","author":"T Ahvenainen","year":"2008","unstructured":"Ahvenainen T, Lehtonen HJ, Lehtonen R et al (2008) Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. Cancer Genet Cytogenet 183:83\u201388","journal-title":"Cancer Genet Cytogenet"},{"key":"9491_CR22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000321336","volume":"221","author":"F Rongioletti","year":"2010","unstructured":"Rongioletti F, Fausti V, Ferrando B et al (2010) A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed\u2019s syndrome). Dermatology 221:378\u2013380","journal-title":"Dermatology"},{"key":"9491_CR23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","volume":"48","author":"B Gardie","year":"2011","unstructured":"Gardie B, Remenieras A, Kattygnarath D et al (2011) Novel FH mutations in families with hereditary leiomyomatosis and renal cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet 48:226\u2013234","journal-title":"J Med Genet"},{"key":"9491_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrurol.2010.234","volume":"8","author":"T Yamasaki","year":"2011","unstructured":"Yamasaki T, Tran TAT, Oz OK et al (2011) Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC. Nat Rev Urol 8:165\u2013171","journal-title":"Nat Rev Urol"},{"key":"9491_CR25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.crad.2008.10.010","volume":"64","author":"M Meister","year":"2009","unstructured":"Meister M, Choyke P, Anderson C et al (2009) Radiological evaluation, management, and surveillance of renal masses in Von-Hippel-Lindau disease. Clin Radiol 64:589\u2013600","journal-title":"Clin Radiol"},{"key":"9491_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs JS, Jung YJ, Mole DR et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143\u2013153","journal-title":"Cancer Cell"},{"key":"9491_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA, Armour SM, MacKenzie ED et al (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77\u201385","journal-title":"Cancer Cell"},{"key":"9491_CR28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrclinonc.2009.170","volume":"6","author":"TK Choueiri","year":"2009","unstructured":"Choueiri TK, Atkins MB (2009) Targeted therapies: sunitinib in RCC-expanded access equals expanded benefit? Nat Rev Clin Oncol 6:679\u2013680","journal-title":"Nat Rev Clin Oncol"},{"key":"9491_CR29","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/cncr.24211","volume":"115","author":"ER Plimack","year":"2009","unstructured":"Plimack ER, Tannir N, Lin E, Bekele BN, Jonasch E (2009) Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. Cancer 115:1859\u20131866","journal-title":"Cancer"},{"key":"9491_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/CAD.0b013e3283442039","volume":"22","author":"A Ravaud","year":"2011","unstructured":"Ravaud A, Bello CL (2011) Exposure-response relationships in patients with metastatic renal cell carcinoma receiving sunitinib: maintaining optimum efficacy in clinical practice. Anticancer Drugs 22:377\u2013383","journal-title":"Anticancer Drugs"},{"key":"9491_CR31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12032-009-9177-0","volume":"26","author":"JP Dutcher","year":"2009","unstructured":"Dutcher JP, de Souza P, McDermott D et al (2009) Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies. Med Oncol 26:202\u2013209","journal-title":"Med Oncol"},{"key":"9491_CR32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2230.2005.01977.x","volume":"31","author":"GS Chuang","year":"2006","unstructured":"Chuang GS, Martinez-Mir A, Engler DE et al (2006) Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene. Clin Exp Dermatol 31:118\u2013121","journal-title":"Clin Exp Dermatol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-011-9491-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T04:32:36Z","timestamp":1686457956000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-011-9491-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9491"],"URL":"https:\/\/doi.org\/10.1007\/s10689-011-9491-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,16]]}}}